Skip to main content

ENvue Medical, Inc.

FEED
Exchange
OTC
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001326706

No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding ENvue Medical, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of FEED: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders2019−1
Shares1.65M1.83M+170.3K (+10.3%)
Value$1.72M$2.12M+$394.0K (+22.9%)

New holders (4)

Institutions that held ENvue Medical, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to FEED in Q1 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC130,466$151.0K0.00%
Millennium Management LLC30,245$35.0K0.00%
Tower Research Capital LLC (TRC)7,038$8.00K0.00%
Citigroup Inc6,207$7.00K0.00%

Sold out (5)

Institutions that held ENvue Medical, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of FEED in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Goldman Sachs Group Inc61,759$64.0K
Susquehanna International Group, LLP21,241$22.0K
Bridgeway Capital Management, LLC15,700$16.0K
Steel Peak Wealth Management LLC13,425$14.0K
Two Sigma Investments, LP11,244$12.0K